NGM BIOPHARMACEUTICALS INC Annual Depreciation in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ngm Biopharmaceuticals Inc quarterly/annual Depreciation history and growth rate from 2017 to 2023.
  • Ngm Biopharmaceuticals Inc Depreciation for the quarter ending December 31, 2023 was $512K, a 15.8% decline year-over-year.
  • Ngm Biopharmaceuticals Inc Depreciation for the twelve months ending December 31, 2023 was $2.22M, a 45% decline year-over-year.
  • Ngm Biopharmaceuticals Inc annual Depreciation for 2023 was $2.22M, a 45% decline from 2022.
  • Ngm Biopharmaceuticals Inc annual Depreciation for 2022 was $4.04M, a 33.7% decline from 2021.
  • Ngm Biopharmaceuticals Inc annual Depreciation for 2021 was $6.09M, a 7.11% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.22M -$1.81M -45% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 $4.04M -$2.05M -33.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 $6.09M -$466K -7.11% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-11
2020 $6.56M -$1.05M -13.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $7.61M +$382K +5.29% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $7.22M +$782K +12.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 $6.44M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.